Paolo Spagnolo

Pulmonary fibrosis secondary to COVID-19: a call to arms?

Paolo Spagnolo, Elisabetta Balestro, Stefano Aliberti et al. · The Lancet Respiratory Medicine · 2020 · 498 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +13

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

Peter M. George, Paolo Spagnolo, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2020 · 346 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis

Michael Kreuter, Wim Wuyts, Elisabetta Renzoni et al. · The Lancet Respiratory Medicine · 2016 · 219 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

A Polymorphism in the<i>CTGF</i>Promoter Region Associated with Systemic Sclerosis

Carmen Fonseca, Gisela Lindahl, Markella Ponticos et al. · New England Journal of Medicine · 2007 · 201 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients

Kaïs Ahmad, Thomas Barba, D. Gamondès et al. · Respiratory Medicine · 2016 · 160 citations · Full text

Medicine, Internal Medicine, Pathology +16